Interaction of VP3(110-121) peptide with hepatocyte and erythrocyte membrane models

P. Sospedra, M. A. Alsina, I. Haro, C. Mestres, M. A. Busquets

Research output: Indexed journal article Articlepeer-review

6 Citations (Scopus)


The use of synthetic peptides in the goal of developing a new, inexpensive vaccine against hepatitis A virus is one of the encouraging approaches followed by many laboratories. These peptides have to be well characterized, being their physicochemical properties one of the most relevant points to control. In that sense, one can consider the study of the peptide interaction with lipid monolayers by means of the Wilhelmy plate method, to gain insight into the possible mechanism of action at the membrane level. The peptide chosen corresponds to the lineal epitope of hepatitis A virus VP3(110-121). As far as the lipids used are concerned, they were selected according to the composition of hepatocytes and erythrocytes because these structures seem to play an important role in hepatitis proliferation and infection. The peptide was able to accommodate into lipid monolayers. Interaction was slightly lower in the hepatocyte model than in the erythrocyte model, probably due to the presence of cholesterol in the hepatocyte membrane.

Original languageEnglish
Pages (from-to)130-136
Number of pages7
JournalJournal of Colloid and Interface Science
Issue number1
Publication statusPublished - 1 Mar 1999
Externally publishedYes


  • Erythrocytes
  • Hepatitis A virus
  • Hepatocytes
  • Lipid monolayers
  • Lipid- peptide interaction


Dive into the research topics of 'Interaction of VP3(110-121) peptide with hepatocyte and erythrocyte membrane models'. Together they form a unique fingerprint.

Cite this